We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Pennant Group
PNTG
$1.36B
| $1.47M | ﹤0.01% |
75,128
-45,240
| -38% | -$762K |
|
|
EA
1677
DELISTED
Electronic Arts
EA
| $1.47M | ﹤0.01% |
11,109
-156,895
| -93% | -$21.5M |
|
1678
American Electric Power
AEP
$68.4B
| $1.47M | ﹤0.01% |
17,100
-128,530
| -88% | -$10.4M |
|
|
AUTL
1679
Autolus Therapeutics
AUTL
$562M
| $1.46M | ﹤0.01% |
228,842
-28,414
| -11% | -$177K |
|
1680
Otter Tail
OTTR
$3.94B
| $1.46M | ﹤0.01% |
16,867
-30,926
| -65% | -$2.69M |
|
|
EFXT
1681
Enerflex
EFXT
$2.44B
| $1.46M | ﹤0.01% |
+249,778
| New | +$1.34M |
|
1682
Telos
TLS
$358M
| $1.45M | ﹤0.01% |
349,573
-16,589
| -5% | -$65.7K |
|
|
SUM
1683
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.45M | ﹤0.01% |
32,572
-17,275
| -35% | -$683K |
|
1684
Integer Holdings
ITGR
$4.26B
| $1.45M | ﹤0.01% |
+12,441
| New | +$1.32M |
|
1685
Garrett Motion
GTX
$5.57B
| $1.45M | ﹤0.01% |
+145,716
| New | +$1.34M |
|
1686
Fidelity National Financial
FNF
$13.5B
| $1.44M | ﹤0.01% |
27,204
+4
| +0% | +$202 |
|
|
GTHX
1687
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.44M | ﹤0.01% |
334,131
+172,068
| +106% | +$600K |
|
1688
Barrett Business Services
BBSI
$804M
| $1.44M | ﹤0.01% |
45,556
-9,980
| -18% | -$290K |
|
1689
Intrepid Potash
IPI
$469M
| $1.44M | ﹤0.01% |
69,055
-16,580
| -19% | -$331K |
|
1690
Hancock Whitney
HWC
$6.24B
| $1.44M | ﹤0.01% |
31,191
+26,591
| +578% | +$1.18M |
|
1691
ON Semiconductor
ON
$31.6B
| $1.44M | ﹤0.01% |
+19,519
| New | +$1.49M |
|
|
LAND
1692
Gladstone Land Corp
LAND
$360M
| $1.43M | ﹤0.01% |
107,491
-64,799
| -38% | -$875K |
|
|
CAN
1693
Canaan Creative
CAN
$159M
| $1.43M | ﹤0.01% |
+943,223
| New | +$1.6M |
|
1694
Bruker
BRKR
$8.14B
| $1.43M | ﹤0.01% |
15,200
-56,517
| -79% | -$4.55M |
|
1695
Praxis Precision Medicines
PRAX
$10.1B
| $1.43M | ﹤0.01% |
23,372
+13,946
| +148% | +$626K |
|
1696
York Water
YORW
$514M
| $1.42M | ﹤0.01% |
39,269
-55
| -0.1% | -$1.98K |
|
|
FOLD
1697
DELISTED
Amicus Therapeutics
FOLD
| $1.42M | ﹤0.01% |
120,536
+75,183
| +166% | +$961K |
|
1698
Sturm, Ruger & Co
RGR
$593M
| $1.42M | ﹤0.01% |
+30,752
| New | +$1.36M |
|
1699
Haverty Furniture Companies
HVT
$454M
| $1.42M | ﹤0.01% |
41,510
-30,770
| -43% | -$1.05M |
|
|
CMBT
1700
CMB.TECH NV
CMBT
$4.73B
| $1.41M | ﹤0.01% |
85,000
-104,558
| -55% | -$1.82M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.